Phase 4 Asthma Clinical Trials
46 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 46 trials
Recruiting
Phase 4
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice
Asthma (Diagnosis)Allergic Rhinitis
Karolinska Institutet40 enrolled2 locationsNCT07651891
Recruiting
Phase 4
Ventilation and Perfusion in Asthmatics
Asthma
University of Miami40 enrolled1 locationNCT07426458
Recruiting
Phase 4
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Asthma
Regeneron Pharmaceuticals250 enrolled84 locationsNCT06572228
Recruiting
Phase 4
Dosing of Steroids for Acute Asthma Given in the Emergency Department - a Pilot Randomised Feasibility Trial of Dexamethasone in Children
Acute asthmaDexamethasone
Sheffield Children's NHS Foundation Trust104 enrolled1 locationNCT07402707
Recruiting
Phase 4
45th Multicenter Airway Research Collaboration
AsthmaAsthma AcuteAsthma Exacerbation+1 more
Massachusetts General Hospital1,860 enrolled1 locationNCT07166939
Recruiting
Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Asthma
Sanofi1,324 enrolled249 locationsNCT05097287
Recruiting
Phase 4
CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma
Moderate to Severe Asthma
Washington University School of Medicine2,000 enrolled7 locationsNCT07241117
Recruiting
Phase 4
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
Asthma
Sally E. Wenzel MD30 enrolled1 locationNCT04743791
Recruiting
Phase 4
Individualizing Treatment for Asthma in Primary Care (Full Study)
AsthmaAsthma AttackAsthma Exacerbations
DARTNet Institute3,200 enrolled13 locationsNCT07052942
Recruiting
Phase 4
Therapeutic Relevance of Abnormal Airway Morphology in Asthma
Asthma
McMaster University242 enrolled2 locationsNCT06970080
Recruiting
Phase 4
The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
AsthmaCOPD
University of California, San Francisco40 enrolled1 locationNCT06152653
Recruiting
Phase 4
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
AsthmaInflammation
St. Olavs Hospital280 enrolled8 locationsNCT03889743
Recruiting
Phase 4
Viral Infection in Asthma (VIA) Study
Asthma
University of Virginia60 enrolled1 locationNCT04380038
Recruiting
Phase 4
Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol
AsthmaCoughCough Variant Asthma
Dr. Diane Lougheed30 enrolled1 locationNCT03105843
Recruiting
Phase 4
Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs
Asthmatic PatientsMDIAerosol Generating Procedure
Beni-Suef University120 enrolled1 locationNCT06816342
Active
Phase 4
A study comparing two step-wise treatment tracks for adults with asthma: inhaled corticosteroid with formoterol reliever therapy versus short-acting beta-agonist reliever therapy.
Asthma
Medical Research Institute of New Zealand152 enrolled1 locationACTRN12624001488594
Recruiting
Phase 4
Short Treatment with Omalizumab for Severe Asthma
Asthma
Assistance Publique - Hôpitaux de Paris234 enrolled1 locationNCT04763447
Recruiting
Phase 4
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Moderate to Severe Asthma
University of California, San Diego120 enrolled3 locationsNCT06385236
Not Yet Recruiting
Phase 4
Minimising Oral Corticosteroid Use in Asthma using Treatable Traits
Asthma
University of Newcastle300 enrolled2 locationsACTRN12624000533594
Recruiting
Phase 4
Predictive Signature of Benralizumab Response
Severe AsthmaAsthma; Eosinophilic
Nantes University Hospital220 enrolled20 locationsNCT04565483